从“一针难求”到营收骤减,HPV疫苗深陷红海鏖战

21世纪经济报道
Aug 25

21世纪经济报道记者季媛媛、唐唯珂  曾经需要排队数月甚至一年的HPV疫苗,如今正静静躺在冷库中等待接种者。疫苗产业,这是一个从蓝海到红海急速转变的行业。  药企财报较为直接的展现了这一现实。根据企业披露的财报,2025年上半年智飞生物营收同比下降73.06%至49.19亿元,净利润亏损5.97亿元,同比由盈转亏;万泰生物作为国产二价疫苗的领军企业,自2020年上市以来首次出现亏损。其上半年实现...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10